Disease ⇒ Chronic Obstructive Pulmonary Disease {40000195}

Record Keys
Type:	Disease
Parent:	[ ]
Definition:	Chronic Obstructive Pulmonary Disease

Details
Initialisation date:	2021-02-09
Other Terms:	COPD

Meta Information
MedDra ID:	10009033
MedDra Level:	pt
ICD:	[ ]
Category:	[ ]
Zone:	[ ]
Mechanism:	[ ]

Notes:

[ ]

Shared Reference Notes

[1.1]
- Lung microbiota differences may contribute to airway dysfunction and airway disease in milder COPD particularly by the dysbiosis of the members of the Streptococcus, Prevotella, Veillonella, Staphylococcus, and Pseudomonas genera.
[1.2]
- The oral and pulmonary mycobiomes from controls and participants with COPD were dominated by #Candida - Malassezia and Sarocladium were also frequently found in pulmonary samples.
[1.3]
[1.4] [#Smoking]
[1.5] [#Bufei Jianpi formula]
- BJF administration > increased the abundance of Firmicutes and the ratio of Firmicutes to Bacteroides, raising SCFA levels, including acetate, butyrate, and propionate levels. - However, the abundance of Bacteroidetes, Proteobacteria, Spirochaetes, Clostridiaceae, and Treponema decreased. - BJF decreased the gene and protein expression of NLRP3, Caspase-1, IL-8, and IL-1β, and increased GPR43 expression.
[1.6] [#Cystic fibrosis exacerbation, #non-cystic fibrosis bronchiectasis]
[1.7]
- In Neutrophil-predominant COPD altered #Tryptophan metabolism in airway #Lactobacilli is associated with reduced #Indole-3-acetic acid (IAA), which was in turn linked to perturbed host interleukin-22 signalling and epithelial cell apoptosis pathways. - airway microbiome-derived IAA mitigates neutrophilic inflammation, apoptosis, emphysema and lung function decline, via macrophage–epithelial cell cross-talk mediated by interleukin-22. - Intranasal inoculation of two airway #Lactobacilli restored IAA and recapitulated its protective effects in mice.
[1.8]

References Notes

[ ]

↥ Microbiota

‐ Abiotrophia Bronchoalveolar lavage Human [1.9]
‐ Actinomyces Bronchoalveolar lavage Human [1.9]
‐ Aeromonas Bronchoalveolar lavage Human [1.9]
‐ Afipia Bronchoalveolar lavage Human [1.10]
‐ Anaerosporobacter Bronchoalveolar lavage Human [1.9]
‐ Atopobium Bronchoalveolar lavage Human [1.9]
‐ Balneimonas Bronchoalveolar lavage Human [1.9]
‐ Bifidobacterium Bronchoalveolar lavage Human [1.9]
‐ Brevundimonas Bronchoalveolar lavage Human [1.10]
‐ Bulleidia Bronchoalveolar lavage Human [1.9]
‐ Burkholderia Tissue biopsie Human [1.11]
‐ Butyrivibrio Bronchoalveolar lavage Human [1.9]
‐ Campylobacter Bronchoalveolar lavage Human [1.9]
‐ Capnocytophaga Bronchoalveolar lavage Human [1.10]
‐ Catonella Bronchoalveolar lavage Human [1.9]
‐ Centipeda Bronchoalveolar lavage Human [1.9]
‐ Chryseobacterium Sputum Human [1.12]
‐ Clostridium symbiosum Bronchoalveolar lavage Human [1.13]
‐ Corynebacterium Bronchoalveolar lavage Human [1.10]
‐ Cryptobacterium Bronchoalveolar lavage Human [1.9]
‐ Curvibacter Bronchoalveolar lavage Human [1.10]
‐ Desulfobulbus Bronchoalveolar lavage Human [1.9]
‐ Dialister Bronchoalveolar lavage Human [1.9]
‐ Dysgonomonas Bronchoalveolar lavage Human [1.9]
‐ Eubacterium Bronchoalveolar lavage Human [1.9]
‐ Fusobacterium Bronchoalveolar lavage Human [1.9]
‐ Fusobacterium Sputum Human [1.12]
‐ Haemophilus Bronchial wash Human [1.14]
‐ Haemophilus Sputum Human [1.15]
‐ Hallella Bronchoalveolar lavage Human [1.9]
‐ Kingella Bronchoalveolar lavage Human [1.9]
‐ Klebsiella pneumoniae Sputum Human [1.16]
‐ Lactobacilli Ameliorative Lung Mouse
‐ Lactobacillus Oropharynx swab Human [1.17]
‐ Lactobacillus Tissue biopsie Human [1.11]
‐ Leptolyngbya Bronchoalveolar lavage Human [1.10]
‐ Leptotrichia Bronchoalveolar lavage Human [1.9]
‐ Leptotrichia Oropharynx swab Human [1.18]
‐ Moraxella Bronchoalveolar lavage Human [1.10]
‐ Moraxella Sputum Human [1.15]
‐ Neisseria Bronchoalveolar lavage Human [1.10]
‐ Neisseria Sputum Human [1.12]
‐ Nocardioides Bronchoalveolar lavage Human [1.9]
‐ Olsenella Bronchoalveolar lavage Human [1.9]
‐ Oribacterium Bronchoalveolar lavage Human [1.9]
‐ Parvimonas Bronchoalveolar lavage Human [1.9]
‐ Peptostreptococcus Bronchoalveolar lavage Human [1.9]
‐ Porphyromonas Sputum Human [1.12]
‐ Prevotella Bronchoalveolar lavage Human [1.9]
‐ Prevotella Sputum Human [1.12]
‐ Pseudomonas aeruginosa Sputum Human [1.16]
‐ Pseudomonas Bronchial wash Human [1.14]
‐ Pseudomonas Oropharynx swab Human [1.17]
‐ Rothia Bronchoalveolar lavage Human [1.9]
‐ Rothia Sputum Human [1.12]
‐ Selenomonas Bronchoalveolar lavage Human [1.9]
‐ Serratia Bronchoalveolar lavage Human [1.9]
‐ Stenotrophomonas Oropharynx swab Human [1.17]
‐ Streptococcus pneumoniae Sputum Human [1.16]
‐ Streptococcus Bronchoalveolar lavage Human [1.9]
‐ Tannerella Bronchoalveolar lavage Human [1.9]
‐ TM7 Bronchoalveolar lavage Human [1.9]
‐ Undibacterium Bronchoalveolar lavage Human [1.10]
‐ Veillonella dispar Oropharynx swab Human [1.18]
‐ Veillonella Bronchoalveolar lavage Human [1.9]
‐ Veillonella Sputum Human [1.12]

↧ Microbiota

‐ Aanaerobacter Bronchoalveolar lavage Human [1.13]
‐ Acinetobacter Sputum Human [1.12]
‐ Actinobacillus Sputum Human [1.19]
‐ Actinomyces Bronchial wash Human [1.14]
‐ Actinomyces Sputum Human [1.20]
‐ Arthrobacter Bronchoalveolar lavage Human [1.9]
‐ Bacteroidetes Sputum Human [1.12]
‐ Campylobacter Sputum Human [1.12]
‐ Centipeda periodontii Bronchoalveolar lavage Human [1.10]
‐ Citrobacter Bronchoalveolar lavage Human [1.9]
‐ Clostridium Bronchoalveolar lavage Human [1.9]
‐ Corynebacterium Sputum Human [1.12]
‐ Eikenella corrodens Sputum Human [1.19]
‐ Eubacterium saburreum Bronchoalveolar lavage Human [1.10]
‐ Filifactor Oropharynx swab Human [1.18]
‐ Gemella Oropharynx swab Human [1.18]
‐ Granulicatella Sputum Human [1.21]
‐ Haemophilus parahaemolyticus Sputum Human [1.19]
‐ Haemophilus parainfluenzae Bronchoalveolar lavage Human [1.10]
‐ Humicoccus Bronchoalveolar lavage Human [1.9]
‐ Lactobacillus sakei Bronchoalveolar lavage Human [1.10]
‐ Micrococcus luteus Bronchoalveolar lavage Human [1.10]
‐ Modestobacter Bronchoalveolar lavage Human [1.9]
‐ Moraxella Sputum Human [1.19]
‐ Neisseria subflava Sputum Human [1.21]
‐ Neisseria Oropharynx swab Human [1.17]
‐ Novosphingobium Tissue biopsie Human [1.22]
‐ Oribacterium Sputum Human [1.19]
‐ Pasteurellaceae Oropharynx swab Human [1.18]
‐ Porphyromonas endodontalis Oropharynx swab Human [1.18]
‐ Prevotella nanceiensis Oropharynx swab Human [1.18]
‐ Prevotella Bronchial wash Human [1.14]
‐ Prevotella Oropharynx swab Human [1.17]
‐ Propionibacterium acnes Bronchoalveolar lavage Human [1.10]
‐ Selenomonas Bronchoalveolar lavage Human [1.10]
‐ Shewanella Sputum Human [1.12]
‐ Staphylococcus Sputum Human [1.12]
‐ Streptococcus Oropharynx swab Human [1.17]
‐ Streptococcus Sputum Human [1.15]
‐ Terrahaemophilus Bronchoalveolar lavage Human [1.10]
‐ Thermoactinomyces Bronchoalveolar lavage Human [1.9]
‐ Veillonella Bronchial wash Human [1.14]
‐ Veillonella Oropharynx swab Human [1.17]

Impact by Microbiota

[ ]

↥ Metabolome

‐ Indole-3-acetic acid Ameliorative Lung Mouse [1.7]

↧ Metabolome

[ ]

Impact by Metabolome

[ ]

Related Factor

[ ]

Subclass

[ ]

References

[ ]

MetaBiom
Identifier: 40000195
URL: https://www.metabiom.org/disease/95/chronic-obstructive-pulmonary-disease
Keywords: Microbiome, Dysbiosis, Chronic

Common References

[1.1] Lung microbiota associations with clinical features of COPD in the SPIROMICS cohort [2021] [Research] [npj Biofilms and Microbiomes] [Journal] [80001645]
[1.2] The pulmonary mycobiome—A study of subjects with and without chronic obstructive pulmonary disease [2021] [Review] [PLOS ONE] [Journal] [80001751]
[1.3] The lower airways microbiome and antimicrobial peptides in idiopathic pulmonary fibrosis differ from chronic obstructive pulmonary disease [2022] [Study] [PLOS ONE] [Journal] [80002207]
[1.4] The Microbiome in Bronchial Biopsies from Smokers and Ex-Smokers with Stable COPD - A Metatranscriptomic Approach [2022] [Study] [COPD: Journal of Chronic Obstructive Pulmonary Disease] [Journal] [80002287]
[1.5] The Bufei Jianpi Formula Improves Mucosal Immune Function by Remodeling Gut Microbiota Through the SCFAs/GPR43/NLRP3 Pathway in Chronic Obstructive Pulmonary Disease Rats [2022] [Research] [International Journal of Chronic Obstructive Pulmonary Disease] [Journal] [80002414]
[1.6] The respiratory microbiota alpha-diversity in chronic lung diseases: first systematic review and meta-analysis [2022] [Review] [Respiratory Research] [Journal] [80002554]
[1.7] Multi-omics analyses of airway host–microbe interactions in chronic obstructive pulmonary disease identify potential therapeutic interventions [2022] [Study] [Nature Microbiology] [Journal] [80002555]
[1.8] The translational potential of the lung microbiome as a biomarker and a therapeutic target for chronic obstructive pulmonary disease [2023] [Interdisciplinary Medicine] [Journal] [80003460]
[1.9] The lung microbiome in moderate and severe chronic obstructive pulmonary disease. [2012] [PLOS ONE] [Journal] [80000385]
[1.10] Analysis of the airway microbiota of healthy individuals and patients with chronic obstructive pulmonary disease by T-RFLP and clone sequencing. [2013] [PLOS ONE] [Journal] [80000383]
[1.11] The lung tissue microbiome in chronic obstructive pulmonary disease. [2012] [American Journal of Respiratory and Critical Care Medicine] [Journal] [80000384]
[1.12] Metagenome and metatranscriptome profiling of moderate and severe COPD sputum in Taiwanese Han Males [2016] [PLOS ONE] [Journal] [80000876]
[1.13] The lung microbiome in moderate and severe chronic obstructive pulmonary disease [2012] [PLOS ONE] [Journal] [80000472]
[1.14] Community dynamics and the lower airway microbiota in stable chronic obstructive pulmonary disease, smokers and healthy non-smokers. [2016] [Thorax] [Journal] [80000390]
[1.15] Lung microbiome dynamics in COPD exacerbations [2016] [The European Respiratory Journal] [Journal] [80000487]
[1.16] Analysis of the bacterial community in chronic obstructive pulmonary disease sputum samples by denaturing gradient gel electrophoresis and real-time PCR. [2014] [BMC Pulmonary Medicine] [Journal] [80000249]
[1.17] Microbial communities in the upper respiratory tract of patients with asthma and chronic obstructive pulmonary disease. [2014] [PLOS ONE] [Journal] [80000380]
[1.18] Characterization of throat microbial flora in smokers with or without COPD [2017] [International Journal of COPD] [Journal] [80000840]
[1.19] Severity-Related changes of bronchial microbiome in chronic obstructive pulmonary disease [2014] [Journal of Clinical Microbiology] [Journal] [80000381]
[1.20] Sputum microbiota in moderate versus severe patients with COPD [2014] [The European Respiratory Journal] [Journal] [80000382]
[1.21] Symptom-related sputum microbiota in stable chronic obstructive pulmonary disease [2018] [International Journal of COPD] [Journal] [80000841]
[1.22] Novosphingobium and its potential role in Chronic Obstructive Pulmonary Diseases: insights from microbiome studies. [2014] [PLOS ONE] [Journal] [80000379]

MetaBiom only uses strictly necessary session cookies to give you the best possible experience on the website. By selecting "Accept essential cookies" you agree to the use of these cookies.

Disease ⇒ Chronic Obstructive Pulmonary Disease {40000195}

Record Keys

Details

Meta Information

Notes:

Shared Reference Notes

References Notes

Common References